Pharmacogenetics of therapies in rheumatoid arthritis: An update

Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory arthritis. Despite many treatment advances, achieving remission or low-disease activity in RA remains challenging, often requiring trial and error approaches with numerous medications. Precision medicine, particularly pharmacogenomics,...

Full description

Saved in:
Bibliographic Details
Published inBest practice & research. Clinical rheumatology p. 101974
Main Authors Babiker-Mohamed, Mohamed H., Bhandari, Sambhawana, Ranganathan, Prabha
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 20.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory arthritis. Despite many treatment advances, achieving remission or low-disease activity in RA remains challenging, often requiring trial and error approaches with numerous medications. Precision medicine, particularly pharmacogenomics, explores how genetic factors influence drug response in individual patients, and incorporates such factors to develop personalized treatments for individual patients. Genetic variations in drug-metabolizing enzymes, transporters, and targets may contribute to inter-individual differences in drug efficacy and toxicity. Advancements in molecular sequencing have allowed rapid identification of such variants, including single nucleotide polymorphisms (SNPs). This review highlights recent major findings in the pharmacogenetics of therapies in RA, focusing on key genes and SNPs to provide insights into current trends and developments in this field.
AbstractList Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory arthritis. Despite many treatment advances, achieving remission or low-disease activity in RA remains challenging, often requiring trial and error approaches with numerous medications. Precision medicine, particularly pharmacogenomics, explores how genetic factors influence drug response in individual patients, and incorporates such factors to develop personalized treatments for individual patients. Genetic variations in drug-metabolizing enzymes, transporters, and targets may contribute to inter-individual differences in drug efficacy and toxicity. Advancements in molecular sequencing have allowed rapid identification of such variants, including single nucleotide polymorphisms (SNPs). This review highlights recent major findings in the pharmacogenetics of therapies in RA, focusing on key genes and SNPs to provide insights into current trends and developments in this field.
Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory arthritis. Despite many treatment advances, achieving remission or low-disease activity in RA remains challenging, often requiring trial and error approaches with numerous medications. Precision medicine, particularly pharmacogenomics, explores how genetic factors influence drug response in individual patients, and incorporates such factors to develop personalized treatments for individual patients. Genetic variations in drug-metabolizing enzymes, transporters, and targets may contribute to inter-individual differences in drug efficacy and toxicity. Advancements in molecular sequencing have allowed rapid identification of such variants, including single nucleotide polymorphisms (SNPs). This review highlights recent major findings in the pharmacogenetics of therapies in RA, focusing on key genes and SNPs to provide insights into current trends and developments in this field.Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory arthritis. Despite many treatment advances, achieving remission or low-disease activity in RA remains challenging, often requiring trial and error approaches with numerous medications. Precision medicine, particularly pharmacogenomics, explores how genetic factors influence drug response in individual patients, and incorporates such factors to develop personalized treatments for individual patients. Genetic variations in drug-metabolizing enzymes, transporters, and targets may contribute to inter-individual differences in drug efficacy and toxicity. Advancements in molecular sequencing have allowed rapid identification of such variants, including single nucleotide polymorphisms (SNPs). This review highlights recent major findings in the pharmacogenetics of therapies in RA, focusing on key genes and SNPs to provide insights into current trends and developments in this field.
ArticleNumber 101974
Author Babiker-Mohamed, Mohamed H.
Bhandari, Sambhawana
Ranganathan, Prabha
Author_xml – sequence: 1
  givenname: Mohamed H.
  surname: Babiker-Mohamed
  fullname: Babiker-Mohamed, Mohamed H.
– sequence: 2
  givenname: Sambhawana
  surname: Bhandari
  fullname: Bhandari, Sambhawana
– sequence: 3
  givenname: Prabha
  surname: Ranganathan
  fullname: Ranganathan, Prabha
  email: pranganathan@wustl.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39034216$$D View this record in MEDLINE/PubMed
BookMark eNp9kE1LxDAQhoOsuO7qH_AgPXrpmo9u0ogHl8UvWNCDnkOaTmyWbbsmqeC_t6WrRweGGYb3fWGeGZo0bQMIXRC8IJjw6-2iAF8tKKbZcJAiO0KnZMloSoTAk2GnJOUyo1M0C2GLMWOSZidoyiRmGSX8FN29VtrX2rQf0EB0JiStTWIFXu8dhMQ1ia-gq3VsXZloHyvvogs3yapJun2pI5yhY6t3Ac4Pc47eH-7f1k_p5uXxeb3apIZInqW5XZIi51TYvgmG0uSCC8F1X9QSZikTzBQ8B1JiLA1YLi2jTNqy4Esr2Rxdjbl73352EKKqXTCw2-kG2i4ohnNGiWCZ6KV0lBrfhuDBqr13tfbfimA1kFNbNZBTAzk1kutNl4f8rqih_LP8ouoFt6MA-i-_HHgVjIPGQOk8mKjK1v2X_wP6UYAX
Cites_doi 10.1016/j.intimp.2016.05.012
10.1186/ar419
10.1038/nm939
10.1038/tpj.2014.19
10.1016/j.autrev.2019.102350
10.2165/00003495-198600321-00011
10.1016/j.mam.2011.10.014
10.3390/pharmaceutics14091942
10.1016/j.ebiom.2022.104343
10.1016/j.semarthrit.2015.07.001
10.1007/s10067-016-3348-0
10.3389/fimmu.2017.00074
10.1007/s10354-015-0344-y
10.1016/j.rbr.2016.03.005
10.1038/s41397-019-0098-9
10.3389/fimmu.2021.672255
10.3390/genes11060679
10.1186/s13075-018-1544-9
10.1002/acr.24596
10.1038/s41598-020-60467-8
10.1016/j.lfs.2019.116744
10.1007/BF00918651
10.1016/0006-2952(79)90039-X
10.3389/fimmu.2021.631603
10.7326/0003-4819-101-3-377
10.3748/wjg.v23.i27.4958
10.1095/biolreprod.102.004242
10.1073/pnas.1205435109
10.1182/blood.V84.2.564.564
10.1177/10600280211002053
10.1007/s00296-017-3650-4
10.1056/NEJM197309062891001
10.2217/pgs-2022-0074
10.1136/annrheumdis-2011-200424
10.1002/acr.24834
10.1111/cpr.12437
10.1007/s00296-017-3726-1
10.1016/S0140-6736(07)60784-3
10.3390/ijms24044110
10.3390/genes15020234
10.1016/j.immuni.2005.01.018
10.1016/j.metabol.2019.06.010
10.1056/NEJM200011303432201
10.1016/S0140-6736(77)90831-5
10.1093/rheumatology/ker257
10.1038/ni1066
10.3389/fimmu.2017.00475
10.1002/art.38331
10.1186/s12920-022-01171-6
10.1093/hmg/ddn245
10.1159/000289196
10.1007/s40265-017-0775-4
10.3389/fimmu.2020.00740
10.2217/pgs-2020-0146
10.1136/annrheumdis-2013-204405
10.1056/NEJM198503283121303
10.1186/s13075-023-03209-1
10.1007/s12026-013-8405-z
10.1038/s41397-020-0168-z
ContentType Journal Article
Copyright 2024 The Authors
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
Copyright_xml – notice: 2024 The Authors
– notice: Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
DBID 6I.
AAFTH
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.berh.2024.101974
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-1770
ExternalDocumentID 10_1016_j_berh_2024_101974
39034216
S1521694224000457
Genre Journal Article
Review
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
23N
4.4
457
4G.
53G
5GY
5RE
5VS
6I.
6J9
7-5
71M
8P~
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABBQC
ABLJU
ABMAC
ABMZM
ABXDB
ACDAQ
ACGFS
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
K-O
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OI0
OV-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
UV1
Z5R
ZGI
~G-
AAXKI
AFJKZ
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c1964-8f51b8627f62710edc876776aaaa2f13f2373cb68e1d009cef69f3239fdb65f93
IEDL.DBID AIKHN
ISSN 1521-6942
1532-1770
IngestDate Sat Oct 26 04:39:47 EDT 2024
Thu Sep 26 21:49:06 EDT 2024
Thu Oct 24 09:20:05 EDT 2024
Sat Jul 27 15:41:31 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Pharmacogenetics
DMARDs
Rheumatoid arthritis
Biologics
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1964-8f51b8627f62710edc876776aaaa2f13f2373cb68e1d009cef69f3239fdb65f93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1521694224000457
PMID 39034216
PQID 3083217347
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3083217347
crossref_primary_10_1016_j_berh_2024_101974
pubmed_primary_39034216
elsevier_sciencedirect_doi_10_1016_j_berh_2024_101974
PublicationCentury 2000
PublicationDate 2024-Jul-20
PublicationDateYYYYMMDD 2024-07-20
PublicationDate_xml – month: 07
  year: 2024
  text: 2024-Jul-20
  day: 20
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Best practice & research. Clinical rheumatology
PublicationTitleAlternate Best Pract Res Clin Rheumatol
PublicationYear 2024
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Murdaca, Tonacci, Negrini (bib64) 2019; 18
Eektimmerman, Swen, Madhar, Allaart, Guchelaar (bib21) 2020; 20
Chuang, Ulevitch (bib49) 2004; 5
Fraenkel, Bathon, England (bib6) 2021; 73
Yuan, Shao, Li (bib44) 2017; 37
Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050 | Institute for Health Metrics and Evaluation. Accessed February 11, 2024.
Cavalli, Eriksson, Sundbaum (bib28) 2022; 23
Narváez, Magallares, Díaz Torné (bib67) 2016; 45
Bank, Andersen, Burisch (bib50) 2014; 14
van Hamburg, Asmawidjaja, Davelaar (bib65) 2012; 71
Londono, Saldarriaga, Rueda (bib24) 2020; 13
Latini, De Benedittis, Conigliaro (bib66) 2024; 15
Yu, Constien, Dear (bib29) 2005; 22
Christakos, Li, De La Cruz, Bikle (bib61) 2019; 98
Kung, Dennis, Ma (bib22) 2014; 66
Rituximab: Principles of use and adverse effects in rheumatoid arthritis - UpToDate. Accessed March 5, 2024.
Chen, Lv, Ma, Liu (bib31) 2018; 51
Shaker, Alnoury, Hegazy, El Haddad, Sayed, Hamdy (bib43) 2016; 56
Pullar, Capell (bib36) 1986; 32
Yan, Aldrich (bib59) 2012; 109
Szekanecz, Meskó, Poliska (bib10) 2013; 56
Falvo, Tsytsykova, Goldfeld (bib48) 2010; 11
Finckh, Gilbert, Hodkinson (bib5) 2022; 18
Rosenblatt (bib20) 2001; 24
Yee, Kim, Han, Lee, Yoon, Gwak (bib37) 2020; 10
de Taeye, Bentlage, Mebius (bib74) 2020; 11
Peppercorn (bib34) 1984; 101
Wang, Kong, Zhang (bib56) 2021; 12
Sainz, Riera, Moya (bib9) 2023; 25
Li, Hu, Li (bib23) 2016; 38
.
Huizinga, Fleischmann, Jasson (bib68) 2014; 73
Grk, Milic, Dolzan (bib26) 2020; 20
Ooi, Chen, Cantorna (bib62) 2012; 33
Márquez, Maldonado Montoro, Pérez Ramírez (bib75) 2021; 11
Das, Eastwood, McManus, Sircus (bib35) 1973; 289
Ravaei, Pulsatelli, Assirelli (bib46) 2023; 24
Cheng, Li, Chen (bib32) 2003; 68
Bluett, Sergeant, MacGregor (bib16) 2018; 20
Galivan (bib13) 1980; 17
Cen, Huang, Zhang (bib45) 2017; 36
Szeto, Cheng, Rosowsky (bib19) 1979; 28
Smolen, Aletaha, Koeller, Weisman, Emery (bib70) 2007; 370
Robinson, Yusof, Davies (bib72) 2022; 86
Cecchin, Stocco (bib7) 2020; 11
Weinblatt, Coblyn, Fox (bib12) 1985; 312
Bathon, Martin, Fleischmann (bib15) 2000; 343
Chan, Cronstein (bib14) 2002; 4
Naushad, Alrokayan, Almajhdi, Hussain (bib25) 2021; 55
Barredo, Synold, Laver (bib18) 1994; 84
Illescas-Montes, Melguizo-Rodríguez, Ruiz, Costela-Ruiz (bib63) 2019; 233
Epidemiology of, risk factors for, and possible causes of rheumatoid arthritis - UpToDate. Accessed February 11, 2024.
Koch, Robinson, Radosevich, Pope (bib58) 1990; 10
Blair, Deeks (bib73) 2017; 77
Kim, Kim, Oh (bib51) 2021; 11
Feldmann, Maini (bib41) 2003; 9
Hunter, Boytsov, Zhang, Schroeder, Michaud, Araujo (bib4) 2017; 37
Aluko, Ranganathan (bib42) 2022; vol. 2547
Sainz, Riera, Moya (bib69) 2022; 14
Makarem, Hareedy, Hassanien, Ahmed, Hetta, Mohamed (bib38) 2021; 22
Afroz, Giddaluru, Vishwakarma, Naz, Khan, Khan (bib30) 2017; 8
Smolen, Aletaha, Barton (bib2) 2018; 4
Iwaszko, Wielińska, Świerkot (bib53) 2021; 12
Maxwell, Potter, Hyrich (bib54) 2008; 17
Myasoedova, Athreya, Crowson (bib27) 2022; 74
Sánchez-Maldonado, Cáliz, López-Nevot (bib57) 2021; 12
Hooijberg, Broxterman, Kool (bib17) 1999; 59
Gao, Tan, Cao (bib39) 2022; 15
Goh, Midwood (bib47) 2012; 51
Azad Khan, Piris, Truelove (bib33) 1977; 2
Griesenauer, Paczesny (bib52) 2017; 8
Dere, Suto (bib11) 2009; 6
Netz, Carter, Eichenberger (bib55) 2017; 23
Aneesh, Sonal Sekar, Jose, Chandran, Zachariah (bib8) 2009; 1
Radner, Aletaha (bib40) 2015; 165
Tatematsu, Funami, Ishii, Seya, Obuse, Matsumoto (bib60) 2015; 195
Huizinga (10.1016/j.berh.2024.101974_bib68) 2014; 73
Hunter (10.1016/j.berh.2024.101974_bib4) 2017; 37
Smolen (10.1016/j.berh.2024.101974_bib70) 2007; 370
Sánchez-Maldonado (10.1016/j.berh.2024.101974_bib57) 2021; 12
Murdaca (10.1016/j.berh.2024.101974_bib64) 2019; 18
Kung (10.1016/j.berh.2024.101974_bib22) 2014; 66
Cavalli (10.1016/j.berh.2024.101974_bib28) 2022; 23
Yee (10.1016/j.berh.2024.101974_bib37) 2020; 10
Kim (10.1016/j.berh.2024.101974_bib51) 2021; 11
Chen (10.1016/j.berh.2024.101974_bib31) 2018; 51
Dere (10.1016/j.berh.2024.101974_bib11) 2009; 6
Das (10.1016/j.berh.2024.101974_bib35) 1973; 289
Iwaszko (10.1016/j.berh.2024.101974_bib53) 2021; 12
Sainz (10.1016/j.berh.2024.101974_bib69) 2022; 14
10.1016/j.berh.2024.101974_bib71
Gao (10.1016/j.berh.2024.101974_bib39) 2022; 15
Márquez (10.1016/j.berh.2024.101974_bib75) 2021; 11
Bank (10.1016/j.berh.2024.101974_bib50) 2014; 14
Blair (10.1016/j.berh.2024.101974_bib73) 2017; 77
Chan (10.1016/j.berh.2024.101974_bib14) 2002; 4
Chuang (10.1016/j.berh.2024.101974_bib49) 2004; 5
Szekanecz (10.1016/j.berh.2024.101974_bib10) 2013; 56
Feldmann (10.1016/j.berh.2024.101974_bib41) 2003; 9
Afroz (10.1016/j.berh.2024.101974_bib30) 2017; 8
Christakos (10.1016/j.berh.2024.101974_bib61) 2019; 98
Ooi (10.1016/j.berh.2024.101974_bib62) 2012; 33
Smolen (10.1016/j.berh.2024.101974_bib2) 2018; 4
Grk (10.1016/j.berh.2024.101974_bib26) 2020; 20
Londono (10.1016/j.berh.2024.101974_bib24) 2020; 13
Aluko (10.1016/j.berh.2024.101974_bib42) 2022; vol. 2547
Radner (10.1016/j.berh.2024.101974_bib40) 2015; 165
Galivan (10.1016/j.berh.2024.101974_bib13) 1980; 17
Eektimmerman (10.1016/j.berh.2024.101974_bib21) 2020; 20
Azad Khan (10.1016/j.berh.2024.101974_bib33) 1977; 2
Griesenauer (10.1016/j.berh.2024.101974_bib52) 2017; 8
Rosenblatt (10.1016/j.berh.2024.101974_bib20) 2001; 24
Koch (10.1016/j.berh.2024.101974_bib58) 1990; 10
Yuan (10.1016/j.berh.2024.101974_bib44) 2017; 37
Hooijberg (10.1016/j.berh.2024.101974_bib17) 1999; 59
Narváez (10.1016/j.berh.2024.101974_bib67) 2016; 45
10.1016/j.berh.2024.101974_bib3
Yan (10.1016/j.berh.2024.101974_bib59) 2012; 109
10.1016/j.berh.2024.101974_bib1
Netz (10.1016/j.berh.2024.101974_bib55) 2017; 23
Wang (10.1016/j.berh.2024.101974_bib56) 2021; 12
Cecchin (10.1016/j.berh.2024.101974_bib7) 2020; 11
Fraenkel (10.1016/j.berh.2024.101974_bib6) 2021; 73
Maxwell (10.1016/j.berh.2024.101974_bib54) 2008; 17
Ravaei (10.1016/j.berh.2024.101974_bib46) 2023; 24
Sainz (10.1016/j.berh.2024.101974_bib9) 2023; 25
Cen (10.1016/j.berh.2024.101974_bib45) 2017; 36
Szeto (10.1016/j.berh.2024.101974_bib19) 1979; 28
Tatematsu (10.1016/j.berh.2024.101974_bib60) 2015; 195
Yu (10.1016/j.berh.2024.101974_bib29) 2005; 22
Makarem (10.1016/j.berh.2024.101974_bib38) 2021; 22
Bluett (10.1016/j.berh.2024.101974_bib16) 2018; 20
van Hamburg (10.1016/j.berh.2024.101974_bib65) 2012; 71
Shaker (10.1016/j.berh.2024.101974_bib43) 2016; 56
Falvo (10.1016/j.berh.2024.101974_bib48) 2010; 11
Latini (10.1016/j.berh.2024.101974_bib66) 2024; 15
Naushad (10.1016/j.berh.2024.101974_bib25) 2021; 55
Bathon (10.1016/j.berh.2024.101974_bib15) 2000; 343
Aneesh (10.1016/j.berh.2024.101974_bib8) 2009; 1
Cheng (10.1016/j.berh.2024.101974_bib32) 2003; 68
de Taeye (10.1016/j.berh.2024.101974_bib74) 2020; 11
Finckh (10.1016/j.berh.2024.101974_bib5) 2022; 18
Peppercorn (10.1016/j.berh.2024.101974_bib34) 1984; 101
Illescas-Montes (10.1016/j.berh.2024.101974_bib63) 2019; 233
Robinson (10.1016/j.berh.2024.101974_bib72) 2022; 86
Barredo (10.1016/j.berh.2024.101974_bib18) 1994; 84
Goh (10.1016/j.berh.2024.101974_bib47) 2012; 51
Pullar (10.1016/j.berh.2024.101974_bib36) 1986; 32
Myasoedova (10.1016/j.berh.2024.101974_bib27) 2022; 74
Weinblatt (10.1016/j.berh.2024.101974_bib12) 1985; 312
Li (10.1016/j.berh.2024.101974_bib23) 2016; 38
References_xml – volume: 14
  start-page: 526
  year: 2014
  end-page: 534
  ident: bib50
  article-title: Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease
  publication-title: Pharmacogenomics J
  contributor:
    fullname: Burisch
– volume: 20
  start-page: 784
  year: 2020
  end-page: 791
  ident: bib26
  article-title: Analysis of association of ADORA2A and ADORA3 polymorphisms genotypes/haplotypes with efficacy and toxicity of methotrexate in patients with Rheumatoid arthritis
  publication-title: Pharmacogenomics J
  contributor:
    fullname: Dolzan
– volume: 11
  start-page: 27
  year: 2010
  end-page: 60
  ident: bib48
  article-title: Transcriptional control of the TNF gene
  publication-title: Curr Dir Autoimmun
  contributor:
    fullname: Goldfeld
– volume: 38
  start-page: 8
  year: 2016
  end-page: 15
  ident: bib23
  article-title: The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: a meta-analysis
  publication-title: Int Immunopharm
  contributor:
    fullname: Li
– volume: 8
  start-page: 475
  year: 2017
  ident: bib52
  article-title: The ST2/IL-33 Axis in immune cells during inflammatory diseases
  publication-title: Front Immunol
  contributor:
    fullname: Paczesny
– volume: 11
  year: 2020
  ident: bib7
  article-title: Pharmacogenomics and personalized medicine
  publication-title: Genes
  contributor:
    fullname: Stocco
– volume: 20
  year: 2018
  ident: bib16
  article-title: Risk factors for oral methotrexate failure in patients with inflammatory polyarthritis: results from a UK prospective cohort study
  publication-title: Arthritis Res Ther
  contributor:
    fullname: MacGregor
– volume: 51
  start-page: 7
  year: 2012
  end-page: 23
  ident: bib47
  article-title: Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis
  publication-title: Rheumatol Oxf Engl
  contributor:
    fullname: Midwood
– volume: 5
  start-page: 495
  year: 2004
  end-page: 502
  ident: bib49
  article-title: Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors
  publication-title: Nat Immunol
  contributor:
    fullname: Ulevitch
– volume: 9
  start-page: 1245
  year: 2003
  end-page: 1250
  ident: bib41
  article-title: Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
  publication-title: Nat Med
  contributor:
    fullname: Maini
– volume: 15
  year: 2024
  ident: bib66
  article-title: The rs11568820 variant in the promoter region of vitamin D receptor gene is associated with clinical remission in rheumatoid arthritis patients receiving tumor necrosis factor inhibitors
  publication-title: Genes
  contributor:
    fullname: Conigliaro
– volume: 73
  start-page: 924
  year: 2021
  end-page: 939
  ident: bib6
  article-title: American college of rheumatology guideline for the treatment of rheumatoid arthritis
  publication-title: Arthritis Care Res
  contributor:
    fullname: England
– volume: 59
  start-page: 2532
  year: 1999
  end-page: 2535
  ident: bib17
  article-title: Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2
  publication-title: Cancer Res
  contributor:
    fullname: Kool
– volume: 18
  start-page: 591
  year: 2022
  end-page: 602
  ident: bib5
  article-title: Global epidemiology of rheumatoid arthritis
  publication-title: Nat Rev Rheumatol
  contributor:
    fullname: Hodkinson
– volume: 195
  start-page: 4933
  year: 2015
  end-page: 4942
  ident: bib60
  article-title: LRRC59 regulates trafficking of nucleic acid-sensing TLRs from the endoplasmic reticulum via association with UNC93B1
  publication-title: J Immunol Baltim Md
  contributor:
    fullname: Matsumoto
– volume: 18
  year: 2019
  ident: bib64
  article-title: Emerging role of vitamin D in autoimmune diseases: an update on evidence and therapeutic implications
  publication-title: Autoimmun Rev
  contributor:
    fullname: Negrini
– volume: 12
  year: 2021
  ident: bib56
  article-title: Tumor necrosis factor alpha -308G/A gene polymorphisms combined with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio predicts the efficacy and safety of anti-TNF-α therapy in patients with ankylosing spondylitis, rheumatoid arthritis, and psoriasis arthritis
  publication-title: Front Pharmacol
  contributor:
    fullname: Zhang
– volume: 56
  start-page: 414
  year: 2016
  end-page: 420
  ident: bib43
  article-title: Methylene tetrahydrofolate reductase, transforming growth factor-β1 and lymphotoxin-α genes polymorphisms and susceptibility to rheumatoid arthritis
  publication-title: Rev Bras Reumatol
  contributor:
    fullname: Hamdy
– volume: 98
  start-page: 112
  year: 2019
  end-page: 120
  ident: bib61
  article-title: New developments in our understanding of vitamin metabolism, action and treatment
  publication-title: Metabolism
  contributor:
    fullname: Bikle
– volume: 22
  start-page: 1201
  year: 2021
  end-page: 1209
  ident: bib38
  article-title: Frequency and impact of DHODH, ABCG2 and CYP2C19 SNPs on the therapeutic efficacy, tolerability and toxicity of leflunomide
  publication-title: Pharmacogenomics
  contributor:
    fullname: Mohamed
– volume: 12
  year: 2021
  ident: bib57
  article-title: Validation of GWAS-identified variants for anti-TNF drug response in rheumatoid arthritis: a meta-analysis of two large cohorts
  publication-title: Front Immunol
  contributor:
    fullname: López-Nevot
– volume: 14
  year: 2022
  ident: bib69
  article-title: Role of IL6R genetic variants in predicting response to tocilizumab in patients with rheumatoid arthritis
  publication-title: Pharmaceutics
  contributor:
    fullname: Moya
– volume: 233
  year: 2019
  ident: bib63
  article-title: Vitamin D and autoimmune diseases
  publication-title: Life Sci
  contributor:
    fullname: Costela-Ruiz
– volume: 86
  year: 2022
  ident: bib72
  article-title: Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity
  publication-title: EBioMedicine
  contributor:
    fullname: Davies
– volume: 84
  start-page: 564
  year: 1994
  end-page: 569
  ident: bib18
  article-title: Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia
  publication-title: Blood
  contributor:
    fullname: Laver
– volume: 71
  start-page: 606
  year: 2012
  end-page: 612
  ident: bib65
  article-title: TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation
  publication-title: Ann Rheum Dis
  contributor:
    fullname: Davelaar
– volume: 1
  start-page: 191
  year: 2009
  end-page: 194
  ident: bib8
  article-title: Pharmacogenomics: the right drug to the right person
  publication-title: J Clin Med Res
  contributor:
    fullname: Zachariah
– volume: 25
  start-page: 226
  year: 2023
  ident: bib9
  article-title: Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis
  publication-title: Arthritis Res Ther
  contributor:
    fullname: Moya
– volume: 77
  start-page: 1221
  year: 2017
  end-page: 1233
  ident: bib73
  article-title: Abatacept: a review in rheumatoid arthritis
  publication-title: Drugs
  contributor:
    fullname: Deeks
– volume: 13
  year: 2020
  ident: bib24
  article-title: Pharmacogenetic aspects of methotrexate in a cohort of Colombian patients with rheumatoid arthritis
  publication-title: Biomed Rep
  contributor:
    fullname: Rueda
– volume: 66
  start-page: 1111
  year: 2014
  end-page: 1120
  ident: bib22
  article-title: RFC1 80G>A is a genetic determinant of methotrexate efficacy in rheumatoid arthritis: a human genome epidemiologic review and meta-analysis of observational studies
  publication-title: Arthritis Rheumatol Hoboken NJ
  contributor:
    fullname: Ma
– volume: 11
  year: 2021
  ident: bib51
  article-title: Association of TLR 9 gene polymorphisms with remission in patients with rheumatoid arthritis receiving TNF-α inhibitors and development of machine learning models
  publication-title: Sci Rep
  contributor:
    fullname: Oh
– volume: 370
  start-page: 1861
  year: 2007
  end-page: 1874
  ident: bib70
  article-title: New therapies for treatment of rheumatoid arthritis
  publication-title: Lancet
  contributor:
    fullname: Emery
– volume: 10
  start-page: 192
  year: 1990
  end-page: 199
  ident: bib58
  article-title: Distribution of CD45RA and CD45RO T-lymphocyte subsets in rheumatoid arthritis synovial tissue
  publication-title: J Clin Immunol
  contributor:
    fullname: Pope
– volume: 24
  start-page: 56
  year: 2001
  end-page: 59
  ident: bib20
  article-title: Methylenetetrahydrofolate reductase
  publication-title: Clin Investig Med Med Clin Exp.
  contributor:
    fullname: Rosenblatt
– volume: 45
  start-page: 386
  year: 2016
  end-page: 390
  ident: bib67
  article-title: Predictive factors for induction of remission in patients with active rheumatoid arthritis treated with tocilizumab in clinical practice
  publication-title: Semin Arthritis Rheum
  contributor:
    fullname: Díaz Torné
– volume: 74
  start-page: 879
  year: 2022
  end-page: 888
  ident: bib27
  article-title: Toward individualized prediction of response to methotrexate in early rheumatoid arthritis: a pharmacogenomics-driven machine learning approach
  publication-title: Arthritis Care Res
  contributor:
    fullname: Crowson
– volume: 36
  start-page: 287
  year: 2017
  end-page: 297
  ident: bib45
  article-title: Associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with genetic susceptibility to rheumatoid arthritis: a meta-analysis
  publication-title: Clin Rheumatol
  contributor:
    fullname: Zhang
– volume: 20
  start-page: 159
  year: 2020
  end-page: 168
  ident: bib21
  article-title: Predictive genetic biomarkers for the efficacy of methotrexate in rheumatoid arthritis: a systematic review
  publication-title: Pharmacogenomics J
  contributor:
    fullname: Guchelaar
– volume: 11
  start-page: 740
  year: 2020
  ident: bib74
  article-title: FcγR binding and ADCC activity of human IgG allotypes
  publication-title: Front Immunol
  contributor:
    fullname: Mebius
– volume: 68
  start-page: 190
  year: 2003
  end-page: 198
  ident: bib32
  article-title: NYD-SP16, a novel gene associated with spermatogenesis of human testis
  publication-title: Biol Reprod
  contributor:
    fullname: Chen
– volume: 17
  start-page: 3532
  year: 2008
  end-page: 3538
  ident: bib54
  article-title: Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis
  publication-title: Hum Mol Genet
  contributor:
    fullname: Hyrich
– volume: 11
  year: 2021
  ident: bib75
  article-title: Influence of the FCGR2A rs1801274 and FCGR3A rs396991 polymorphisms on response to abatacept in patients with rheumatoid arthritis
  publication-title: J Personalized Med
  contributor:
    fullname: Pérez Ramírez
– volume: 4
  start-page: 1
  year: 2018
  end-page: 23
  ident: bib2
  article-title: Rheumatoid arthritis
  publication-title: Nat Rev Dis Prim
  contributor:
    fullname: Barton
– volume: 10
  year: 2020
  ident: bib37
  article-title: The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis
  publication-title: Sci Rep
  contributor:
    fullname: Gwak
– volume: 23
  start-page: 4958
  year: 2017
  end-page: 4967
  ident: bib55
  article-title: Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn's disease
  publication-title: World J Gastroenterol
  contributor:
    fullname: Eichenberger
– volume: 37
  start-page: 557
  year: 2017
  end-page: 569
  ident: bib44
  article-title: Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis
  publication-title: Rheumatol Int
  contributor:
    fullname: Li
– volume: 4
  start-page: 266
  year: 2002
  end-page: 273
  ident: bib14
  article-title: Molecular action of methotrexate in inflammatory diseases
  publication-title: Arthritis Res
  contributor:
    fullname: Cronstein
– volume: 8
  start-page: 74
  year: 2017
  ident: bib30
  article-title: A comprehensive gene expression meta-analysis identifies novel immune signatures in rheumatoid arthritis patients
  publication-title: Front Immunol
  contributor:
    fullname: Khan
– volume: 312
  start-page: 818
  year: 1985
  end-page: 822
  ident: bib12
  article-title: Efficacy of low-dose methotrexate in rheumatoid arthritis
  publication-title: N Engl J Med
  contributor:
    fullname: Fox
– volume: 343
  start-page: 1586
  year: 2000
  end-page: 1593
  ident: bib15
  article-title: A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
  publication-title: N Engl J Med
  contributor:
    fullname: Fleischmann
– volume: 28
  start-page: 2633
  year: 1979
  end-page: 2637
  ident: bib19
  article-title: Human thymidylate synthetase--III. Effects of methotrexate and folate analogs
  publication-title: Biochem Pharmacol
  contributor:
    fullname: Rosowsky
– volume: 73
  start-page: 1626
  year: 2014
  end-page: 1634
  ident: bib68
  article-title: Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial
  publication-title: Ann Rheum Dis
  contributor:
    fullname: Jasson
– volume: 6
  start-page: 13
  year: 2009
  end-page: 16
  ident: bib11
  article-title: The role of pharmacogenetics and pharmacogenomics in improving translational medicine
  publication-title: Clin Cases Miner Bone Metab
  contributor:
    fullname: Suto
– volume: 24
  year: 2023
  ident: bib46
  article-title: MTHFR c.665C>T and c.1298A>C polymorphisms in tailoring personalized anti-TNF-α therapy for rheumatoid arthritis
  publication-title: Int J Mol Sci
  contributor:
    fullname: Assirelli
– volume: 101
  start-page: 377
  year: 1984
  end-page: 386
  ident: bib34
  article-title: Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development
  publication-title: Ann Intern Med
  contributor:
    fullname: Peppercorn
– volume: 22
  start-page: 451
  year: 2005
  end-page: 465
  ident: bib29
  article-title: Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry
  publication-title: Immunity
  contributor:
    fullname: Dear
– volume: 32
  start-page: 54
  year: 1986
  end-page: 57
  ident: bib36
  article-title: Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review
  publication-title: Drugs
  contributor:
    fullname: Capell
– volume: 17
  start-page: 105
  year: 1980
  end-page: 110
  ident: bib13
  article-title: Evidence for the cytotoxic activity of polyglutamate derivatives of methotrexate
  publication-title: Mol Pharmacol
  contributor:
    fullname: Galivan
– volume: 37
  start-page: 1551
  year: 2017
  end-page: 1557
  ident: bib4
  article-title: Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014
  publication-title: Rheumatol Int
  contributor:
    fullname: Araujo
– volume: 109
  start-page: 7917
  year: 2012
  end-page: 7922
  ident: bib59
  article-title: BK potassium channel modulation by leucine-rich repeat-containing proteins
  publication-title: Proc Natl Acad Sci U S A
  contributor:
    fullname: Aldrich
– volume: 51
  year: 2018
  ident: bib31
  article-title: PLCγ2 promotes apoptosis while inhibits proliferation in rat hepatocytes through PKCD/JNK MAPK and PKCD/p38 MAPK signalling
  publication-title: Cell Prolif
  contributor:
    fullname: Liu
– volume: 2
  start-page: 892
  year: 1977
  end-page: 895
  ident: bib33
  article-title: An experiment to determine the active therapeutic moiety of sulphasalazine
  publication-title: Lancet Lond Engl
  contributor:
    fullname: Truelove
– volume: 15
  start-page: 23
  year: 2022
  ident: bib39
  article-title: Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions
  publication-title: BMC Med Genom
  contributor:
    fullname: Cao
– volume: 33
  start-page: 77
  year: 2012
  end-page: 82
  ident: bib62
  article-title: Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors?
  publication-title: Mol Aspect Med
  contributor:
    fullname: Cantorna
– volume: 56
  start-page: 325
  year: 2013
  end-page: 333
  ident: bib10
  article-title: Pharmacogenetics and pharmacogenomics in rheumatology
  publication-title: Immunol Res
  contributor:
    fullname: Poliska
– volume: 289
  start-page: 491
  year: 1973
  end-page: 495
  ident: bib35
  article-title: Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype
  publication-title: N Engl J Med
  contributor:
    fullname: Sircus
– volume: vol. 2547
  year: 2022
  ident: bib42
  article-title: Pharmacogenetics of drug therapies in rheumatoid arthritis
  publication-title: Pharmacogenomics in drug discovery and development
  contributor:
    fullname: Ranganathan
– volume: 55
  start-page: 1429
  year: 2021
  end-page: 1438
  ident: bib25
  article-title: Influence of RFC1 c.80A>G polymorphism on methotrexate-mediated toxicity and therapeutic efficacy in rheumatoid arthritis: a meta-analysis
  publication-title: Ann Pharmacother
  contributor:
    fullname: Hussain
– volume: 12
  year: 2021
  ident: bib53
  article-title: IL-33 gene polymorphisms as potential biomarkers of disease susceptibility and response to TNF inhibitors in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis patients
  publication-title: Front Immunol
  contributor:
    fullname: Świerkot
– volume: 23
  start-page: 813
  year: 2022
  end-page: 820
  ident: bib28
  article-title: Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate
  publication-title: Pharmacogenomics
  contributor:
    fullname: Sundbaum
– volume: 165
  start-page: 3
  year: 2015
  end-page: 9
  ident: bib40
  article-title: Anti-TNF in rheumatoid arthritis: an overview
  publication-title: Wien Med Wochenschr
  contributor:
    fullname: Aletaha
– volume: 38
  start-page: 8
  year: 2016
  ident: 10.1016/j.berh.2024.101974_bib23
  article-title: The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: a meta-analysis
  publication-title: Int Immunopharm
  doi: 10.1016/j.intimp.2016.05.012
  contributor:
    fullname: Li
– volume: 4
  start-page: 266
  issue: 4
  year: 2002
  ident: 10.1016/j.berh.2024.101974_bib14
  article-title: Molecular action of methotrexate in inflammatory diseases
  publication-title: Arthritis Res
  doi: 10.1186/ar419
  contributor:
    fullname: Chan
– volume: 59
  start-page: 2532
  issue: 11
  year: 1999
  ident: 10.1016/j.berh.2024.101974_bib17
  article-title: Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2
  publication-title: Cancer Res
  contributor:
    fullname: Hooijberg
– volume: 9
  start-page: 1245
  issue: 10
  year: 2003
  ident: 10.1016/j.berh.2024.101974_bib41
  article-title: Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
  publication-title: Nat Med
  doi: 10.1038/nm939
  contributor:
    fullname: Feldmann
– volume: 14
  start-page: 526
  issue: 6
  year: 2014
  ident: 10.1016/j.berh.2024.101974_bib50
  article-title: Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease
  publication-title: Pharmacogenomics J
  doi: 10.1038/tpj.2014.19
  contributor:
    fullname: Bank
– volume: 18
  issue: 9
  year: 2019
  ident: 10.1016/j.berh.2024.101974_bib64
  article-title: Emerging role of vitamin D in autoimmune diseases: an update on evidence and therapeutic implications
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2019.102350
  contributor:
    fullname: Murdaca
– volume: 32
  start-page: 54
  issue: Suppl 1
  year: 1986
  ident: 10.1016/j.berh.2024.101974_bib36
  article-title: Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review
  publication-title: Drugs
  doi: 10.2165/00003495-198600321-00011
  contributor:
    fullname: Pullar
– volume: 33
  start-page: 77
  issue: 1
  year: 2012
  ident: 10.1016/j.berh.2024.101974_bib62
  article-title: Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors?
  publication-title: Mol Aspect Med
  doi: 10.1016/j.mam.2011.10.014
  contributor:
    fullname: Ooi
– volume: 14
  issue: 9
  year: 2022
  ident: 10.1016/j.berh.2024.101974_bib69
  article-title: Role of IL6R genetic variants in predicting response to tocilizumab in patients with rheumatoid arthritis
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics14091942
  contributor:
    fullname: Sainz
– volume: 86
  year: 2022
  ident: 10.1016/j.berh.2024.101974_bib72
  article-title: Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2022.104343
  contributor:
    fullname: Robinson
– volume: 1
  start-page: 191
  issue: 4
  year: 2009
  ident: 10.1016/j.berh.2024.101974_bib8
  article-title: Pharmacogenomics: the right drug to the right person
  publication-title: J Clin Med Res
  contributor:
    fullname: Aneesh
– volume: 45
  start-page: 386
  issue: 4
  year: 2016
  ident: 10.1016/j.berh.2024.101974_bib67
  article-title: Predictive factors for induction of remission in patients with active rheumatoid arthritis treated with tocilizumab in clinical practice
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2015.07.001
  contributor:
    fullname: Narváez
– volume: 36
  start-page: 287
  issue: 2
  year: 2017
  ident: 10.1016/j.berh.2024.101974_bib45
  article-title: Associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with genetic susceptibility to rheumatoid arthritis: a meta-analysis
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-016-3348-0
  contributor:
    fullname: Cen
– volume: 8
  start-page: 74
  year: 2017
  ident: 10.1016/j.berh.2024.101974_bib30
  article-title: A comprehensive gene expression meta-analysis identifies novel immune signatures in rheumatoid arthritis patients
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.00074
  contributor:
    fullname: Afroz
– volume: 165
  start-page: 3
  issue: 1–2
  year: 2015
  ident: 10.1016/j.berh.2024.101974_bib40
  article-title: Anti-TNF in rheumatoid arthritis: an overview
  publication-title: Wien Med Wochenschr
  doi: 10.1007/s10354-015-0344-y
  contributor:
    fullname: Radner
– volume: 56
  start-page: 414
  issue: 5
  year: 2016
  ident: 10.1016/j.berh.2024.101974_bib43
  article-title: Methylene tetrahydrofolate reductase, transforming growth factor-β1 and lymphotoxin-α genes polymorphisms and susceptibility to rheumatoid arthritis
  publication-title: Rev Bras Reumatol
  doi: 10.1016/j.rbr.2016.03.005
  contributor:
    fullname: Shaker
– volume: 20
  start-page: 159
  issue: 2
  year: 2020
  ident: 10.1016/j.berh.2024.101974_bib21
  article-title: Predictive genetic biomarkers for the efficacy of methotrexate in rheumatoid arthritis: a systematic review
  publication-title: Pharmacogenomics J
  doi: 10.1038/s41397-019-0098-9
  contributor:
    fullname: Eektimmerman
– volume: 12
  year: 2021
  ident: 10.1016/j.berh.2024.101974_bib56
  publication-title: Front Pharmacol
  contributor:
    fullname: Wang
– volume: 195
  start-page: 4933
  issue: 10
  year: 2015
  ident: 10.1016/j.berh.2024.101974_bib60
  article-title: LRRC59 regulates trafficking of nucleic acid-sensing TLRs from the endoplasmic reticulum via association with UNC93B1
  publication-title: J Immunol Baltim Md
  contributor:
    fullname: Tatematsu
– volume: 12
  year: 2021
  ident: 10.1016/j.berh.2024.101974_bib57
  article-title: Validation of GWAS-identified variants for anti-TNF drug response in rheumatoid arthritis: a meta-analysis of two large cohorts
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.672255
  contributor:
    fullname: Sánchez-Maldonado
– volume: 11
  issue: 6
  year: 2020
  ident: 10.1016/j.berh.2024.101974_bib7
  article-title: Pharmacogenomics and personalized medicine
  publication-title: Genes
  doi: 10.3390/genes11060679
  contributor:
    fullname: Cecchin
– volume: 20
  issue: 1
  year: 2018
  ident: 10.1016/j.berh.2024.101974_bib16
  article-title: Risk factors for oral methotrexate failure in patients with inflammatory polyarthritis: results from a UK prospective cohort study
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-018-1544-9
  contributor:
    fullname: Bluett
– volume: 73
  start-page: 924
  issue: 7
  year: 2021
  ident: 10.1016/j.berh.2024.101974_bib6
  article-title: American college of rheumatology guideline for the treatment of rheumatoid arthritis
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.24596
  contributor:
    fullname: Fraenkel
– volume: 10
  issue: 1
  year: 2020
  ident: 10.1016/j.berh.2024.101974_bib37
  article-title: The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-60467-8
  contributor:
    fullname: Yee
– volume: 233
  year: 2019
  ident: 10.1016/j.berh.2024.101974_bib63
  article-title: Vitamin D and autoimmune diseases
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2019.116744
  contributor:
    fullname: Illescas-Montes
– volume: 10
  start-page: 192
  issue: 4
  year: 1990
  ident: 10.1016/j.berh.2024.101974_bib58
  article-title: Distribution of CD45RA and CD45RO T-lymphocyte subsets in rheumatoid arthritis synovial tissue
  publication-title: J Clin Immunol
  doi: 10.1007/BF00918651
  contributor:
    fullname: Koch
– volume: 28
  start-page: 2633
  issue: 17
  year: 1979
  ident: 10.1016/j.berh.2024.101974_bib19
  article-title: Human thymidylate synthetase--III. Effects of methotrexate and folate analogs
  publication-title: Biochem Pharmacol
  doi: 10.1016/0006-2952(79)90039-X
  contributor:
    fullname: Szeto
– volume: 12
  year: 2021
  ident: 10.1016/j.berh.2024.101974_bib53
  article-title: IL-33 gene polymorphisms as potential biomarkers of disease susceptibility and response to TNF inhibitors in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis patients
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.631603
  contributor:
    fullname: Iwaszko
– ident: 10.1016/j.berh.2024.101974_bib3
– volume: 101
  start-page: 377
  issue: 3
  year: 1984
  ident: 10.1016/j.berh.2024.101974_bib34
  article-title: Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-101-3-377
  contributor:
    fullname: Peppercorn
– volume: 23
  start-page: 4958
  issue: 27
  year: 2017
  ident: 10.1016/j.berh.2024.101974_bib55
  article-title: Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn's disease
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v23.i27.4958
  contributor:
    fullname: Netz
– volume: 68
  start-page: 190
  issue: 1
  year: 2003
  ident: 10.1016/j.berh.2024.101974_bib32
  article-title: NYD-SP16, a novel gene associated with spermatogenesis of human testis
  publication-title: Biol Reprod
  doi: 10.1095/biolreprod.102.004242
  contributor:
    fullname: Cheng
– volume: 109
  start-page: 7917
  issue: 20
  year: 2012
  ident: 10.1016/j.berh.2024.101974_bib59
  article-title: BK potassium channel modulation by leucine-rich repeat-containing proteins
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1205435109
  contributor:
    fullname: Yan
– volume: 13
  issue: 4
  year: 2020
  ident: 10.1016/j.berh.2024.101974_bib24
  article-title: Pharmacogenetic aspects of methotrexate in a cohort of Colombian patients with rheumatoid arthritis
  publication-title: Biomed Rep
  contributor:
    fullname: Londono
– volume: 84
  start-page: 564
  issue: 2
  year: 1994
  ident: 10.1016/j.berh.2024.101974_bib18
  article-title: Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia
  publication-title: Blood
  doi: 10.1182/blood.V84.2.564.564
  contributor:
    fullname: Barredo
– volume: 11
  issue: 1
  year: 2021
  ident: 10.1016/j.berh.2024.101974_bib51
  article-title: Association of TLR 9 gene polymorphisms with remission in patients with rheumatoid arthritis receiving TNF-α inhibitors and development of machine learning models
  publication-title: Sci Rep
  contributor:
    fullname: Kim
– volume: 55
  start-page: 1429
  issue: 12
  year: 2021
  ident: 10.1016/j.berh.2024.101974_bib25
  article-title: Influence of RFC1 c.80A>G polymorphism on methotrexate-mediated toxicity and therapeutic efficacy in rheumatoid arthritis: a meta-analysis
  publication-title: Ann Pharmacother
  doi: 10.1177/10600280211002053
  contributor:
    fullname: Naushad
– volume: 18
  start-page: 591
  issue: 10
  year: 2022
  ident: 10.1016/j.berh.2024.101974_bib5
  article-title: Global epidemiology of rheumatoid arthritis
  publication-title: Nat Rev Rheumatol
  contributor:
    fullname: Finckh
– volume: 37
  start-page: 557
  issue: 4
  year: 2017
  ident: 10.1016/j.berh.2024.101974_bib44
  article-title: Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-017-3650-4
  contributor:
    fullname: Yuan
– volume: 289
  start-page: 491
  issue: 10
  year: 1973
  ident: 10.1016/j.berh.2024.101974_bib35
  article-title: Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype
  publication-title: N Engl J Med
  doi: 10.1056/NEJM197309062891001
  contributor:
    fullname: Das
– volume: 23
  start-page: 813
  issue: 15
  year: 2022
  ident: 10.1016/j.berh.2024.101974_bib28
  article-title: Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate
  publication-title: Pharmacogenomics
  doi: 10.2217/pgs-2022-0074
  contributor:
    fullname: Cavalli
– volume: 6
  start-page: 13
  issue: 1
  year: 2009
  ident: 10.1016/j.berh.2024.101974_bib11
  article-title: The role of pharmacogenetics and pharmacogenomics in improving translational medicine
  publication-title: Clin Cases Miner Bone Metab
  contributor:
    fullname: Dere
– volume: 71
  start-page: 606
  issue: 4
  year: 2012
  ident: 10.1016/j.berh.2024.101974_bib65
  article-title: TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2011-200424
  contributor:
    fullname: van Hamburg
– volume: 74
  start-page: 879
  issue: 6
  year: 2022
  ident: 10.1016/j.berh.2024.101974_bib27
  article-title: Toward individualized prediction of response to methotrexate in early rheumatoid arthritis: a pharmacogenomics-driven machine learning approach
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.24834
  contributor:
    fullname: Myasoedova
– volume: 17
  start-page: 105
  issue: 1
  year: 1980
  ident: 10.1016/j.berh.2024.101974_bib13
  article-title: Evidence for the cytotoxic activity of polyglutamate derivatives of methotrexate
  publication-title: Mol Pharmacol
  contributor:
    fullname: Galivan
– ident: 10.1016/j.berh.2024.101974_bib71
– volume: 4
  start-page: 1
  issue: 1
  year: 2018
  ident: 10.1016/j.berh.2024.101974_bib2
  article-title: Rheumatoid arthritis
  publication-title: Nat Rev Dis Prim
  contributor:
    fullname: Smolen
– volume: 51
  issue: 3
  year: 2018
  ident: 10.1016/j.berh.2024.101974_bib31
  article-title: PLCγ2 promotes apoptosis while inhibits proliferation in rat hepatocytes through PKCD/JNK MAPK and PKCD/p38 MAPK signalling
  publication-title: Cell Prolif
  doi: 10.1111/cpr.12437
  contributor:
    fullname: Chen
– volume: 37
  start-page: 1551
  issue: 9
  year: 2017
  ident: 10.1016/j.berh.2024.101974_bib4
  article-title: Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-017-3726-1
  contributor:
    fullname: Hunter
– volume: 370
  start-page: 1861
  issue: 9602
  year: 2007
  ident: 10.1016/j.berh.2024.101974_bib70
  article-title: New therapies for treatment of rheumatoid arthritis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)60784-3
  contributor:
    fullname: Smolen
– volume: 24
  issue: 4
  year: 2023
  ident: 10.1016/j.berh.2024.101974_bib46
  article-title: MTHFR c.665C>T and c.1298A>C polymorphisms in tailoring personalized anti-TNF-α therapy for rheumatoid arthritis
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms24044110
  contributor:
    fullname: Ravaei
– volume: 24
  start-page: 56
  issue: 1
  year: 2001
  ident: 10.1016/j.berh.2024.101974_bib20
  article-title: Methylenetetrahydrofolate reductase
  publication-title: Clin Investig Med Med Clin Exp.
  contributor:
    fullname: Rosenblatt
– volume: 15
  issue: 2
  year: 2024
  ident: 10.1016/j.berh.2024.101974_bib66
  article-title: The rs11568820 variant in the promoter region of vitamin D receptor gene is associated with clinical remission in rheumatoid arthritis patients receiving tumor necrosis factor inhibitors
  publication-title: Genes
  doi: 10.3390/genes15020234
  contributor:
    fullname: Latini
– volume: 22
  start-page: 451
  issue: 4
  year: 2005
  ident: 10.1016/j.berh.2024.101974_bib29
  article-title: Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry
  publication-title: Immunity
  doi: 10.1016/j.immuni.2005.01.018
  contributor:
    fullname: Yu
– volume: 98
  start-page: 112
  year: 2019
  ident: 10.1016/j.berh.2024.101974_bib61
  article-title: New developments in our understanding of vitamin metabolism, action and treatment
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2019.06.010
  contributor:
    fullname: Christakos
– volume: 343
  start-page: 1586
  issue: 22
  year: 2000
  ident: 10.1016/j.berh.2024.101974_bib15
  article-title: A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200011303432201
  contributor:
    fullname: Bathon
– volume: 2
  start-page: 892
  issue: 8044
  year: 1977
  ident: 10.1016/j.berh.2024.101974_bib33
  article-title: An experiment to determine the active therapeutic moiety of sulphasalazine
  publication-title: Lancet Lond Engl
  doi: 10.1016/S0140-6736(77)90831-5
  contributor:
    fullname: Azad Khan
– volume: 51
  start-page: 7
  issue: 1
  year: 2012
  ident: 10.1016/j.berh.2024.101974_bib47
  article-title: Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis
  publication-title: Rheumatol Oxf Engl
  doi: 10.1093/rheumatology/ker257
  contributor:
    fullname: Goh
– volume: 5
  start-page: 495
  issue: 5
  year: 2004
  ident: 10.1016/j.berh.2024.101974_bib49
  article-title: Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors
  publication-title: Nat Immunol
  doi: 10.1038/ni1066
  contributor:
    fullname: Chuang
– ident: 10.1016/j.berh.2024.101974_bib1
– volume: 11
  issue: 6
  year: 2021
  ident: 10.1016/j.berh.2024.101974_bib75
  article-title: Influence of the FCGR2A rs1801274 and FCGR3A rs396991 polymorphisms on response to abatacept in patients with rheumatoid arthritis
  publication-title: J Personalized Med
  contributor:
    fullname: Márquez
– volume: 8
  start-page: 475
  year: 2017
  ident: 10.1016/j.berh.2024.101974_bib52
  article-title: The ST2/IL-33 Axis in immune cells during inflammatory diseases
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.00475
  contributor:
    fullname: Griesenauer
– volume: 66
  start-page: 1111
  issue: 5
  year: 2014
  ident: 10.1016/j.berh.2024.101974_bib22
  article-title: RFC1 80G>A is a genetic determinant of methotrexate efficacy in rheumatoid arthritis: a human genome epidemiologic review and meta-analysis of observational studies
  publication-title: Arthritis Rheumatol Hoboken NJ
  doi: 10.1002/art.38331
  contributor:
    fullname: Kung
– volume: 15
  start-page: 23
  year: 2022
  ident: 10.1016/j.berh.2024.101974_bib39
  article-title: Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions
  publication-title: BMC Med Genom
  doi: 10.1186/s12920-022-01171-6
  contributor:
    fullname: Gao
– volume: 17
  start-page: 3532
  issue: 22
  year: 2008
  ident: 10.1016/j.berh.2024.101974_bib54
  article-title: Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddn245
  contributor:
    fullname: Maxwell
– volume: 11
  start-page: 27
  year: 2010
  ident: 10.1016/j.berh.2024.101974_bib48
  article-title: Transcriptional control of the TNF gene
  publication-title: Curr Dir Autoimmun
  doi: 10.1159/000289196
  contributor:
    fullname: Falvo
– volume: 77
  start-page: 1221
  issue: 11
  year: 2017
  ident: 10.1016/j.berh.2024.101974_bib73
  article-title: Abatacept: a review in rheumatoid arthritis
  publication-title: Drugs
  doi: 10.1007/s40265-017-0775-4
  contributor:
    fullname: Blair
– volume: 11
  start-page: 740
  year: 2020
  ident: 10.1016/j.berh.2024.101974_bib74
  article-title: FcγR binding and ADCC activity of human IgG allotypes
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.00740
  contributor:
    fullname: de Taeye
– volume: 22
  start-page: 1201
  issue: 18
  year: 2021
  ident: 10.1016/j.berh.2024.101974_bib38
  article-title: Frequency and impact of DHODH, ABCG2 and CYP2C19 SNPs on the therapeutic efficacy, tolerability and toxicity of leflunomide
  publication-title: Pharmacogenomics
  doi: 10.2217/pgs-2020-0146
  contributor:
    fullname: Makarem
– volume: 73
  start-page: 1626
  issue: 9
  year: 2014
  ident: 10.1016/j.berh.2024.101974_bib68
  article-title: Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-204405
  contributor:
    fullname: Huizinga
– volume: 312
  start-page: 818
  issue: 13
  year: 1985
  ident: 10.1016/j.berh.2024.101974_bib12
  article-title: Efficacy of low-dose methotrexate in rheumatoid arthritis
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198503283121303
  contributor:
    fullname: Weinblatt
– volume: vol. 2547
  year: 2022
  ident: 10.1016/j.berh.2024.101974_bib42
  article-title: Pharmacogenetics of drug therapies in rheumatoid arthritis
  contributor:
    fullname: Aluko
– volume: 25
  start-page: 226
  issue: 1
  year: 2023
  ident: 10.1016/j.berh.2024.101974_bib9
  article-title: Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-023-03209-1
  contributor:
    fullname: Sainz
– volume: 56
  start-page: 325
  issue: 0
  year: 2013
  ident: 10.1016/j.berh.2024.101974_bib10
  article-title: Pharmacogenetics and pharmacogenomics in rheumatology
  publication-title: Immunol Res
  doi: 10.1007/s12026-013-8405-z
  contributor:
    fullname: Szekanecz
– volume: 20
  start-page: 784
  issue: 6
  year: 2020
  ident: 10.1016/j.berh.2024.101974_bib26
  article-title: Analysis of association of ADORA2A and ADORA3 polymorphisms genotypes/haplotypes with efficacy and toxicity of methotrexate in patients with Rheumatoid arthritis
  publication-title: Pharmacogenomics J
  doi: 10.1038/s41397-020-0168-z
  contributor:
    fullname: Grk
SSID ssj0033924
Score 2.456713
SecondaryResourceType review_article
Snippet Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory arthritis. Despite many treatment advances, achieving remission or low-disease activity in RA...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 101974
SubjectTerms Biologics
DMARDs
Pharmacogenetics
Rheumatoid arthritis
Title Pharmacogenetics of therapies in rheumatoid arthritis: An update
URI https://dx.doi.org/10.1016/j.berh.2024.101974
https://www.ncbi.nlm.nih.gov/pubmed/39034216
https://www.proquest.com/docview/3083217347
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB58gHgR366PJYI3qdsmabL15LIo6xPxAd7CtklwPXSX1b36251pU8GDHiz00NDQ9Mt08k3nEYCjopCWyihF2jkfSRen-M1xGXUl9955m1lHhuLtnRo8y6uX9GUO-k0uDIVVBt1f6_RKW4eWTkCzMxmNOo-08qhMVlGQSEz0PCySkwgtsMXe5fXgrlHIAilA5VzG-yPqEHJn6jCv3E3JJ8ElNWRa_rY-_cY_q3XoYhVWAoFkvXqMazDnynVYug0u8g04uw_FqFEyKEHxnY09q7Os0Chmo5JNX90Meep4ZBm-6WtV1eiU9Uo2m5D5vwnPF-dP_UEUtkmICqqmFXV9muRomGiPZxI7W6CG01oN8eA-EZ4LLYpcdV1ikVEVzqvMCy4yb3OV-kxswUI5Lt0OsG425NKnaJKgoaKEG_Lc55YjK4ulTb1qwXEDjpnU1TBMEyb2ZghKQ1CaGsoWpA1-5secGlTXf_Y7bMA2KOzkwRiWbjx7NyKmjZW0kLoF2_UsfI9DZFTNMFG7_3zqHizTFf235fE-LHxMZ-4ACcdH3ob5k8-kjWLVf7i5bwfx-gKEjNPy
link.rule.ids 315,786,790,4516,24137,27946,27947,45609,45703
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB58gHoR367PCN6kbpukydaTIsqqu4uggrewbRJ2PXSXfVz97c70IXjQg4Ve0pSmX6aTbzqPAJxnmbRURinQzvlAujDGb47LoCW5987bxDoyFLs91X6Tj-_x-wLc1rkwFFZZ6f5SpxfaumppVmg2x8Nh84VWHpXIIgoSiYlehGVkAyGJ9uXnd5yHQAJQuJaxd0Ddq8yZMsgrdRPySHBJDYmWv61Ov7HPYhW634D1ij6ym3KEm7Dg8i1Y6VYO8m24fq5KUaNcUHrilI08K3Os0CRmw5xNBm6OLHU0tAzfc1DUNLpiNzmbj8n434G3-7vX23ZQbZIQZFRLK2j5OErRLNEezyh0NkP9prXq48F9JDwXWmSparnIIp_KnFeJF1wk3qYq9onYhaV8lLt9YK2kz6WP0SBBM0UJ1-epTy1HThZKG3vVgIsaHDMua2GYOkjswxCUhqA0JZQNiGv8zI8ZNais_7zvrAbboKiT_6Kfu9F8akRI2yppIXUD9spZ-B6HSKiWYaQO_vnUU1htv3Y7pvPQezqENbpCf3B5eARLs8ncHSP1mKUnhWh9Abxt0zA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacogenetics+of+therapies+in+rheumatoid+arthritis%3A+An+update&rft.jtitle=Best+practice+%26+research.+Clinical+rheumatology&rft.au=Babiker-Mohamed%2C+Mohamed+H.&rft.au=Bhandari%2C+Sambhawana&rft.au=Ranganathan%2C+Prabha&rft.date=2024-07-20&rft.pub=Elsevier+Ltd&rft.issn=1521-6942&rft.eissn=1532-1770&rft_id=info:doi/10.1016%2Fj.berh.2024.101974&rft.externalDocID=S1521694224000457
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1521-6942&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1521-6942&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1521-6942&client=summon